Mario Chih-Hsiung Karl Deng MD

Heart Failure & Transplantation

Professor, Medicine, University of California Los Angeles David Geffen SOM

200 Medical Plaza DrivewaySte 365CLos Angeles, CA 90095
Phone+1 310-794-2727
Fax+1 310-794-0011

Dr. Deng is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Deng's full profile Already have an account?

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Advanced Heart Failure and Transplant Cardiology, 1992 - 1993
Freie University Berlin Faculty of MedicineClass of 1988

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2014 - 2028
NY State Medical License 2000 - 2028

Awards, Honors, & Recognition

Forbes Best Cardiologist List Forbes, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017

Clinical Trials

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection
COMPLETED
NA
COVID-19 Outcome Prediction Algorithm Start of enrollment: 2022 Aug 08
ACTIVE_NOT_RECRUITING
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Case Report: Exercise-associated changes of leukocyte gene expression in statin-associated myopathy.
Galyna Bondar, Abhinandan Das Mahapatra, Irina Silacheva, Tra-Mi Bao, Thomas Vu
Frontiers in Pharmacology. 2025-01-01
15 citations
Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival.
Philip F Halloran, Katelynn Madill-Thomsen, Arezu Z Aliabadi-Zuckermann, Martin Cadeiras, Marisa G Crespo-Leiro
American Journal of Transplantation. 2024-08-01
2 citations
An Exercise Immune Fitness Test to Unravel Disease Mechanisms-A Proof-of-Concept Heart Failure Study.
Galyna Bondar, Abhinandan Das Mahapatra, Tra-Mi Bao, Irina Silacheva, Adrian Hairapetian
Journal of Clinical Medicine. 2024-05-29

Journal Articles

Heart and Heart‐Liver Transplantation in Adults with Failing Fontan Physiology
Ronald W Busuttil, Ali Nsair, Hillel Laks, Abbas Ardehali, Eugene C DePasquale, Mario C Deng, Jeannette P Lin, Robert S Venick, Leigh C Reardon, Reshma M Biniwale, Fad..., Clinical Transplantation

Press Mentions

Relational Medicine – Personalizing Modern Healthcare: The Practice of High‐Tech Medicine as A RelationalActAugust 14th, 2019
Genomic Blood Test Predicts Survival for Heart Failure Patients After MCS SurgeryDecember 18th, 2017
Genomic Blood Test Predicts Survival Rates After Surgery for Advanced Heart FailureDecember 13th, 2017

Grant Support

Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 PatientsUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2026
Multi-omic Biomarker Discovery and Validation in Heart Transplant Patient PopulationsNEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025